Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2011-1-5
pubmed:abstractText
Mantle cell lymphoma (MCL) is an aggressive B-cell lymphoma with poor prognosis, requiring novel anticancer strategies.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Boronic Acids, http://linkedlifedata.com/resource/pubmed/chemical/Coumarins, http://linkedlifedata.com/resource/pubmed/chemical/Cyclin D1, http://linkedlifedata.com/resource/pubmed/chemical/GUT-70, http://linkedlifedata.com/resource/pubmed/chemical/HSP90 Heat-Shock Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Oncogene Protein v-akt, http://linkedlifedata.com/resource/pubmed/chemical/PMAIP1 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-bcl-2, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-raf, http://linkedlifedata.com/resource/pubmed/chemical/Pyrazines, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Protein p53, http://linkedlifedata.com/resource/pubmed/chemical/bcl-2 Homologous Antagonist-Killer..., http://linkedlifedata.com/resource/pubmed/chemical/bortezomib
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1532-1827
pubmed:author
pubmed:issnType
Electronic
pubmed:day
4
pubmed:volume
104
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
91-100
pubmed:dateRevised
2011-2-18
pubmed:meshHeading
pubmed-meshheading:21139584-Antineoplastic Agents, pubmed-meshheading:21139584-Apoptosis, pubmed-meshheading:21139584-Blotting, Western, pubmed-meshheading:21139584-Boronic Acids, pubmed-meshheading:21139584-Cell Cycle, pubmed-meshheading:21139584-Cell Proliferation, pubmed-meshheading:21139584-Coumarins, pubmed-meshheading:21139584-Cyclin D1, pubmed-meshheading:21139584-Drug Synergism, pubmed-meshheading:21139584-Drug Therapy, Combination, pubmed-meshheading:21139584-Flow Cytometry, pubmed-meshheading:21139584-HSP90 Heat-Shock Proteins, pubmed-meshheading:21139584-Humans, pubmed-meshheading:21139584-Immunoenzyme Techniques, pubmed-meshheading:21139584-Immunoprecipitation, pubmed-meshheading:21139584-Lymphoma, Mantle-Cell, pubmed-meshheading:21139584-Mutation, pubmed-meshheading:21139584-Oncogene Protein v-akt, pubmed-meshheading:21139584-Proto-Oncogene Proteins c-bcl-2, pubmed-meshheading:21139584-Proto-Oncogene Proteins c-raf, pubmed-meshheading:21139584-Pyrazines, pubmed-meshheading:21139584-RNA, Messenger, pubmed-meshheading:21139584-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:21139584-Tumor Cells, Cultured, pubmed-meshheading:21139584-Tumor Suppressor Protein p53, pubmed-meshheading:21139584-bcl-2 Homologous Antagonist-Killer Protein
pubmed:year
2011
pubmed:articleTitle
Antiproliferative and proapoptotic activity of GUT-70 mediated through potent inhibition of Hsp90 in mantle cell lymphoma.
pubmed:affiliation
Department of Clinical Laboratory Medicine, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't